Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The participant will receive weekly intramuscular treatment with AVONEX® (interferon beta
1-a) and bi-monthly high dose intravenous methotrexate with Leucovorin rescue.
Phase:
Phase 4
Details
Lead Sponsor:
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute